Commentary regarding double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria by M Morgan, A Cooke, L Rogers, B Adams-Huet, da Khan. J Allergy Clin Immunol Pract 2: 601-606, 2014

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)102-103
Number of pages2
JournalDermatologic Therapy
Volume28
Issue number2
DOIs
StatePublished - Mar 1 2015

Fingerprint

Dapsone
Anti-Allergic Agents
Histamine Antagonists
Urticaria
Hypersensitivity
Placebos
Therapeutics

Keywords

  • dapsone
  • therapy
  • urticaria

ASJC Scopus subject areas

  • Dermatology

Cite this

@article{98f5eac21ead49a2aa53e9ffeb2b1557,
title = "Commentary regarding double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria by M Morgan, A Cooke, L Rogers, B Adams-Huet, da Khan. J Allergy Clin Immunol Pract 2: 601-606, 2014",
keywords = "dapsone, therapy, urticaria",
author = "Yancey, {Kim B.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1111/dth.12201",
language = "English (US)",
volume = "28",
pages = "102--103",
journal = "Dermatologic Therapy",
issn = "1396-0296",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Commentary regarding double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria by M Morgan, A Cooke, L Rogers, B Adams-Huet, da Khan. J Allergy Clin Immunol Pract 2

T2 - 601-606, 2014

AU - Yancey, Kim B.

PY - 2015/3/1

Y1 - 2015/3/1

KW - dapsone

KW - therapy

KW - urticaria

UR - http://www.scopus.com/inward/record.url?scp=84926196066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926196066&partnerID=8YFLogxK

U2 - 10.1111/dth.12201

DO - 10.1111/dth.12201

M3 - Article

C2 - 25649343

AN - SCOPUS:84926196066

VL - 28

SP - 102

EP - 103

JO - Dermatologic Therapy

JF - Dermatologic Therapy

SN - 1396-0296

IS - 2

ER -